Orrin Stone

Orrin Stone is a seasoned professional in business development and strategy, currently serving at Apogee Therapeutics since July 2023. Prior experience includes roles in venture investment at Cambrian Bio, business development and operations at BridgeBio, and consulting as an associate at McKinsey & Company, where strategic guidance was provided to clients in the pharmaceutical and medical device sectors. Notable contributions at McKinsey involved developing a new operating model for clinical trial management teams, achieving significant reductions in startup times. Orrin has earned a PhD in Pharmacology and completed a graduate program focused on technology commercialization and entrepreneurship, both from the University of North Carolina at Chapel Hill.